---
schema_version: "secwatch.filing_event.v1"
accession: "0001217234-24-000081"
form_type: "8-K"
ticker: "CDNA"
cik: "0001217234"
company_name: "CareDx, Inc."
filed_at: "2024-07-31T23:59:59+00:00"
generated_at: "2026-05-31T14:16:53.685442+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CareDx Q2 revenue $92.3M (+31% YoY); raises FY2024 revenue guidance to $320-$328M

## Summary
- Total revenue $92.3M (+31% YoY); Testing Services revenue $70.9M (+33%); volume 43,700 tests (+17%).
- GAAP net loss narrowed to $1.4M from $25M; non-GAAP net income $13.6M (vs loss of $9.9M).
- Adjusted EBITDA positive $12.9M vs loss of $10.4M; cash $228.9M, no debt.
- Raised FY2024 revenue guidance to $320-$328M (from $274-$282M); adjusted EBITDA guidance to $9-$15M gain.
- Expanded coverage by 27M lives in H1 2024; published SHORE study and Nature Medicine data.

## SEC filing metadata
- accession: 0001217234-24-000081
- form_type: 8-K
- ticker: CDNA
- cik: 0001217234
- company_name: CareDx, Inc.
- filed_at: 2024-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1217234/000121723424000081/0001217234-24-000081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1217234/000121723424000081/cdna-20240731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001217234-24-000081
- JSON: https://secwatch.observer/filing/0001217234-24-000081.json
- Plain text: https://secwatch.observer/filing/0001217234-24-000081.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.